Saturday, 12 September 2026
- Frontiers in TB & Mycobacteriology - TB - TB 2026

Dr. Tianyu Zhang | Frontiers in TB & Mycobacteriology

🔴 Day 2 Live Update An insightful presentation by Dr. Tianyu Zhang on “Research Progress on the Synergistic Lethal Mechanism of Mycobacteria.” Dr. Tianyu Zhang is affiliated with Guangzhou National Laboratory, the State Key Laboratory of Respiratory Disease at the Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, and related research institutions in […]

Dr. Tianyu Zhang

🔴 Day 2 Live Update

An insightful presentation by Dr. Tianyu Zhang on “Research Progress on the Synergistic Lethal Mechanism of Mycobacteria.”

Dr. Tianyu Zhang is affiliated with Guangzhou National Laboratory, the State Key Laboratory of Respiratory Disease at the Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, and related research institutions in Guangzhou, China. His research has focused on mycobacteria, tuberculosis, drug development, and models for studying mycobacterial infections.

His research has included investigations into interactions between mycobacterial respiratory complexes and their relevance to drug-resistant Mycobacterium tuberculosis. Such work contributes to understanding how different cellular systems in mycobacteria interact and how these interactions may inform new approaches to tuberculosis drug discovery.

Dr. Zhang has also contributed to research on Mycobacterium abscessus, including studies examining mechanisms associated with intrinsic drug resistance, as well as research into compounds and therapeutic strategies relevant to drug-resistant mycobacterial infections.

The presentation is part of Day 2’s Host-Pathogen Mechanisms session, bringing attention to research on synergistic lethal mechanisms in mycobacteria and their potential relevance to understanding mycobacterial biology and therapeutic development.

The scientific discussions continue at Frontiers in TB & Mycobacteriology 2026, highlighting research across mycobacterial biology, host-pathogen interactions, drug discovery and tuberculosis.

This conference is organized by Impact Research Communications (IRC)

More info: https://tb.ircconferences.net/ | Frontiers in TB & Mycobacteriology

Leave a comment

Your email address will not be published. Required fields are marked *

Stemxmedia@2026. All Rights Reserved.